AHCO - AdaptHealth Corp Stock Price, Fair Value and News

9.93USD+0.26 (+2.69%)Delayed as of 13 May 2024, 10:03 am ET

Market Summary

USD9.93+0.26

Delayedas of 13 May 2024, 10:03 am

2.69%

AHCO Alerts

Big fall in earnings (Y/Y)

Losses in recent quarter

AHCO Stock Price

View Fullscreen

AHCO RSI Chart

AHCO Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

-1.85

Price/Sales (Trailing)

0.4

EV/EBITDA

-15.27

Price/Free Cashflow

24.2

AHCO Price/Sales (Trailing)

AHCO Profitability

EBT Margin

-22.57%

Return on Equity

-47.36%

Return on Assets

-15.47%

Free Cashflow Yield

4.13%

AHCO Fundamentals

AHCO Revenue

Revenue (TTM)

3.2B

Rev. Growth (Yr)

6.43%

Rev. Growth (Qtr)

-7.66%

AHCO Earnings

Earnings (TTM)

-696.7M

Earnings Growth (Yr)

-112.8%

Earnings Growth (Qtr)

99.16%

Breaking Down AHCO Revenue

52 Week Range

8.0315.37

(Low)(High)

Last 7 days

-11.2%

Last 30 days

-11.6%

Last 90 days

23.8%

Trailing 12 Months

-16.9%

How does AHCO drawdown profile look like?

AHCO Financial Health

Current Ratio

1.33

Debt/Equity

1.47

Debt/Cashflow

0.18

AHCO Investor Care

Buy Backs (1Y)

0.72%

Diluted EPS (TTM)

-5.29

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	3.2B	0	0	0
2023	3.0B	3.1B	3.1B	3.2B
2022	2.7B	2.8B	2.9B	3.0B
2021	1.3B	1.7B	2.1B	2.5B
2020	601.6M	709.5M	857.5M	1.1B
2019	391.4M	437.5M	483.6M	529.6M
2018	0	0	0	345.3M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of AdaptHealth Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 07, 2024	barasch richard a	sold (taxes)	-84,188	9.85	-8,547	interim ceo
Apr 30, 2024	barasch richard a	acquired	-	-	8,829	interim ceo
Mar 18, 2024	clemens jason a	acquired	-	-	128,380	chief financial officer
Mar 12, 2024	flynn james e	sold	-1,229,490	10.7	-114,906	-
Mar 11, 2024	flynn james e	sold	-2,012,560	11.0212	-182,607	-
Mar 08, 2024	flynn james e	sold	-573,652	10.9294	-52,487	-
Mar 02, 2024	barasch richard a	acquired	-	-	21,206	interim ceo
Feb 29, 2024	barasch richard a	sold (taxes)	-91,906	10.23	-8,984	interim ceo
Feb 05, 2024	bush jonathan b	acquired	-	-	57,072	general counsel
Feb 05, 2024	parnes josh	acquired	-	-	231,853	president

Which funds bought or sold AHCO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 10, 2024	CIBC Private Wealth Group, LLC	new	-	1,120	1,120	-%
May 10, 2024	CITIGROUP INC	added	14.02	317,590	714,472	-%
May 10, 2024	VANGUARD GROUP INC	added	8.89	48,239,800	115,304,000	-%
May 10, 2024	Campbell & CO Investment Adviser LLC	added	224	421,829	524,108	0.04%
May 10, 2024	WELLS FARGO & COMPANY/MN	added	14.54	163,031	364,695	-%
May 10, 2024	CORNERCAP INVESTMENT COUNSEL INC	new	-	523,153	523,153	0.08%
May 10, 2024	JPMORGAN CHASE & CO	added	108	2,717,170	3,899,800	-%
May 10, 2024	OSAIC HOLDINGS, INC.	reduced	-31.37	622	8,057	-%
May 10, 2024	CREDIT SUISSE AG/	reduced	-9.98	248,537	838,400	-%
May 10, 2024	PNC Financial Services Group, Inc.	added	6.99	123,112	301,746	-%

Are Funds Buying or Selling AHCO?

Are funds buying AHCO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AHCO

No. of Funds

Unveiling AdaptHealth Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	6.75%	9,199,481	SC 13G/A
Feb 12, 2024	flynn james e	8.71%	13,674,318	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 08, 2024	blackrock inc.	10.3%	14,066,565	SC 13G/A
Aug 28, 2023	everest hill group inc.	7.14%	9,721,412	SC 13D/A
Aug 11, 2023	peloton equity aerocare spv i, l.p.	1.6%	2,220,277	SC 13D/A
May 16, 2023	peloton equity aerocare spv i, l.p.	3.3%	4,460,555	SC 13D/A
Feb 10, 2023	flynn james e	4.9%	7,693,292	SC 13G/A
Feb 09, 2023	vanguard group inc	6.09%	8,211,817	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G

Recent SEC filings of AdaptHealth Corp

View All Filings

Date Filed	Form Type	Document
May 09, 2024	4	Insider Trading
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
May 02, 2024	4	Insider Trading
Apr 26, 2024	ARS	ARS
Apr 26, 2024	DEF 14A	DEF 14A
Apr 17, 2024	8-K	Current Report
Apr 12, 2024	PRE 14A	PRE 14A
Apr 08, 2024	5	Insider Trading
Mar 20, 2024	4	Insider Trading

Peers (Alternatives to AdaptHealth Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.1B	40.3B	-6.91%	-5.44%	32.37	4.52	-2.84%	-3.08%
BDX	67.9B	19.7B	-4.40%	-6.39%	50.95	3.44	4.82%	-17.56%
ALGN	21.1B	3.9B	-15.10%	-8.15%	45.66	5.39	5.72%	46.72%
BAX	18.3B	14.9B	-16.06%	-18.00%	6.92	1.23	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.25%	24.63%	31.45	2.78	6.16%	35.06%
HSIC	9.4B	12.5B	0.37%	-3.65%	24.24	0.76	-0.61%	-18.83%
BIO	7.9B	2.6B	-18.31%	-24.17%	-24.53	3.04	-6.25%	-68.62%
XRAY	5.9B	3.9B	-14.16%	-31.27%	-62.62	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.52%	17.85%	-215.92	8.89	30.82%	65.57%
PDCO	2.3B	6.6B	-0.94%	-	11.71	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-11.63%	-16.91%	-1.85	0.4	7.94%	-1661.78%
ANIK	380.1M	169.3M	-2.43%	-	-4.95	2.25	7.49%	-244.90%
ANGO	242.3M	324.0M	-12.20%	-33.04%	-1.26	0.75	-3.19%	-337.41%
APYX	52.0M	50.5M	12.93%	-52.30%	-2.28	1.03	14.25%	-10.06%
AEMD	3.1M	3.7M	-28.92%	247.06%	-0.25	0.82	5.77%	8.23%

AdaptHealth Corp News

Latest updates

AdaptHealth Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-7.7%	792	858	804	793	745	780	756	728	706	702	653	617	482	348	284	232	191	150	136	124	119
Costs and Expenses	-31.0%	742	1,076	1,265	739	718	754	704	668	655	644	578	552	467	328	271	217	183	149	128	109	114
S&GA Expenses	-100.0%	-	47.00	45.00	50.00	48.00	37.00	41.00	43.00	41.00	35.00	33.00	43.00	57.00	32.00	26.00	17.00	14.00	25.00	12.00	6.00	13.00
EBITDA Margin	-3.1%	-0.07*	-0.07*	0.02*	0.19*	0.18*	0.19*	0.19*	0.21*	0.24*	0.22*	0.17*	0.09*	-	-	-	-	-	-	-	-	-
Interest Expenses	-3.0%	32.00	33.00	32.00	33.00	32.00	31.00	29.00	26.00	25.00	26.00	24.00	23.00	22.00	14.00	12.00	7.00	8.00	8.00	11.00	15.00	6.00
Income Taxes	136.4%	7.00	-18.12	-34.58	5.00	-1.70	5.00	6.00	9.00	6.00	10.00	12.00	12.00	-1.69	-7.23	-4.90	2.00	-1.64	-4.67	1.00	2.00	2.00
Earnings Before Taxes	102.0%	6.00	-271	-487	20.00	15.00	3.00	23.00	24.00	48.00	33.00	70.00	92.00	-5.34	-97.73	-66.90	10.00	-51.09	-17.07	-2.03	0.00	-3.03
EBT Margin	0.2%	-0.23*	-0.23*	-0.14*	0.02*	0.02*	0.03*	0.04*	0.06*	0.09*	0.08*	0.03*	-0.04*	-	-	-	-	-	-	-	-	-
Net Income	99.2%	-2.13	-255	-454	15.00	17.00	-3.44	16.00	15.00	42.00	22.00	58.00	80.00	-3.64	-74.76	-51.03	8.00	-49.45	-10.13	-3.69	-1.72	-5.45
Net Income Margin	-1.3%	-0.21*	-0.21*	-0.14*	0.01*	0.01*	0.02*	0.03*	0.05*	0.08*	0.06*	0.03*	-0.03*	-	-	-	-	-	-	-	-	-
Free Cashflow	-158.3%	-38.86	67.00	22.00	4.00	51.00	-45.99	13.00	26.00	-10.71	37.00	-33.16	85.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.1%	4,504	4,509	4,725	5,203	5,283	5,220	5,238	5,202	5,204	5,250	5,192	4,688	4,520	1,813	1,556	742	665	547	257	256	255
Current Assets	1.1%	656	649	585	568	647	585	632	605	615	670	823	591	504	363	484	264	195	181	1.00	1.00	1.00
Cash Equivalents	3.2%	80.00	77.00	56.00	45.00	101	46.00	111	119	119	150	337	178	132	100	272	111	48.00	77.00	9.00	2.00	15.00
Inventory	-4.4%	109	114	116	115	136	128	125	103	100	123	100	82.00	75.00	59.00	46.00	24.00	18.00	13.00	-	-	-
Net PPE	1.4%	502	495	-	-	-	-	473	455	425	399	341	309	299	110	102	83.00	87.00	64.00	-	-	-
Goodwill	-0.2%	2,718	2,725	3,041	3,552	3,545	3,545	12.00	5.00	2.00	3,513	29.00	46.00	40.00	999	36.00	50.00	1.00	267	44.00	-	-
Liabilities	-0.3%	3,033	3,042	2,985	3,016	3,116	3,062	3,078	3,064	3,084	3,184	3,197	2,794	2,728	1,533	1,211	814	765	612	411	210	9.00
Current Liabilities	-8.3%	493	537	448	458	524	456	467	435	444	500	502	606	513	422	315	257	191	154	3.00	2.00	1.00
Long Term Debt	3.1%	2,159	2,095	2,127	2,136	2,169	2,153	2,162	2,171	2,180	2,184	2,187	1,776	1,749	777	723	443	464	395	-	-	-
LT Debt, Current	-25.0%	40.00	53.00	40.00	40.00	40.00	35.00	30.00	25.00	20.00	20.00	20.00	97.00	18.00	8.00	8.00	3.00	3.00	2.00	-	-	-
LT Debt, Non Current	-100.0%	-	2,095	2,127	2,136	2,169	2,153	2,162	2,171	2,180	2,184	2,187	1,776	1,749	777	723	443	464	395	-	-	-
Shareholder's Equity	0.9%	1,471	1,458	1,732	2,187	2,167	2,151	2,160	2,138	2,121	2,067	1,994	1,894	1,792	281	315	8.00	-	-	5.00	5.00	5.00
Retained Earnings	-0.3%	-654	-652	-398	56.00	42.00	26.00	29.00	13.00	-1.27	-43.02	-65.96	-124	-203	-199	-118	-70.34	-74.81	-40.26	2.00	2.00	3.00
Additional Paid-In Capital	0.2%	2,155	2,150	2,145	2,140	2,135	2,130	2,126	2,119	2,113	2,107	2,057	2,016	1,994	558	485	17.00	26.00	4.00	3.00	3.00	2.00
Shares Outstanding	0.4%	133	133	135	135	134	134	134	134	134	126	124	120	-	-	-	-	-	-	-	-	-
Minority Interest	12.5%	9.00	8.00	7.00	6.00	8.00	7.00	6.00	4.00	5.00	5.00	4.00	4.00	4.00	-74.04	-45.83	-42.59	-46.35	-26.96	-	-	-
Float	-	-	-	-	1,260	-	-	-	1,510	-	-	-	2,170	-	-	-	185	-	-	-	253	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-68.4%	49,035	155,266	98,833	86,319	140,248	96,920	107,023	103,473	66,451	100,929	27,126	129,244	18,380	50,347	34,279	86,628	24,380	17,244	17,138	9,804	16,232
Share Based Compensation	-12.6%	4,533	5,184	4,521	6,847	5,916	5,613	5,562	5,720	5,502	3,929	5,365	7,447	8,582	7,701	5,502	3,244	2,223	5,264	400	183	5,223
Cashflow From Investing	2.8%	-87,891	-90,417	-77,098	-100,196	-89,567	-145,795	-95,345	-89,933	-80,098	-266,246	-186,480	-158,263	-1,213,764	-188,606	-509,765	-6,003	-111,329	-22,471	-23,689	-12,530	-26,179
Cashflow From Financing	194.1%	41,290	-43,860	-10,718	-42,398	4,448	-15,591	-19,749	-14,159	-16,552	-21,710	317,819	75,071	1,227,559	-34,097	637,217	-18,202	58,235	73,282	13,215	-9,984	-368
Buy Backs	-100.0%	-	20,051	-	-	9,224	-	10,617	3,375	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

AHCO Income Statement

2024-03-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net revenue	$ 792,497	$ 744,626
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Costs and expenses:
Cost of net revenue	$ 675,693	$ 655,396
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 48,378	$ 47,521
Depreciation and amortization, excluding patient equipment depreciation	11,365	15,532
Goodwill impairment (note 5)	6,530	0
Total costs and expenses	741,966	718,449
Operating income	50,531	26,177
Interest expense, net	32,472	31,955
Change in fair value of warrant liability (note 10)	7,453	(21,914)
Other loss, net	5,105	1,175
Income before income taxes	5,501	14,961
Income tax expense (benefit)	6,610	(1,714)
Net (loss) income	(1,109)	16,675
Income attributable to noncontrolling interest	1,025	968
Net (loss) income attributable to AdaptHealth Corp.	$ (2,134)	$ 15,707
Weighted average common shares outstanding - basic (in shares)	132,914	134,525
Weighted average common shares outstanding - diluted (in shares)	132,914	135,976
Basic net (loss) income per share (note 11) (in dollars per share)	$ (0.02)	$ 0.11
Diluted net loss per share (note 11) (in dollars per share)	$ (0.02)	$ (0.06)

AHCO Balance Sheet

2024-03-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 79,566	$ 77,132
Accounts receivable	429,558	388,910
Inventory	108,585	113,642
Prepaid and other current assets	38,272	69,338
Total current assets	655,981	649,022
Equipment and other fixed assets, net	501,892	495,101
Operating lease right-of-use assets	111,232	110,465
Finance lease right-of-use assets	30,427	31,962
Goodwill	2,718,428	2,724,958
Identifiable intangible assets, net	124,591	130,160
Other assets	20,001	21,128
Deferred tax assets	341,141	345,854
Total Assets	4,503,693	4,508,650
Current liabilities:
Accounts payable and accrued expenses	340,234	391,994
Current portion of long-term debt	40,000	53,368
Current portion of operating lease obligations	31,530	29,270
Current portion of finance lease obligations	9,245	9,122
Contract liabilities	34,040	38,570
Warrant liability	11,474	4,021
Other liabilities	26,169	10,654
Total current liabilities	492,692	536,999
Long-term debt, less current portion	2,159,161	2,094,614
Operating lease obligations, less current portion	84,115	85,529
Finance lease obligations, less current portion	21,057	22,746
Other long-term liabilities	275,639	302,093
Total Liabilities	3,032,664	3,041,981
Commitments and contingencies (note 14)
Stockholders' Equity:
Common Stock, par value of $0.0001 per share, 300,000,000 shares authorized; 133,194,999 and 132,634,850 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	13	13
Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 shares issued and outstanding as of March 31, 2024 and December 31, 2023	1	1
Treasury stock, at cost (3,935,035 shares at March 31, 2024 and December 31, 2023)	(43,267)	(43,267)
Additional paid-in capital	2,154,564	2,149,951
Accumulated deficit	(654,734)	(652,600)
Accumulated other comprehensive income	5,212	4,356
Total stockholders' equity attributable to AdaptHealth Corp.	1,461,789	1,458,454
Noncontrolling interest in subsidiary	9,240	8,215
Total Stockholders' Equity	1,471,029	1,466,669
Total Liabilities and Stockholders' Equity	$ 4,503,693	$ 4,508,650

About AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

WEBSITE	https://adapthealth.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	10900

AdaptHealth Corp Frequently Asked Questions

What is the ticker symbol for AdaptHealth Corp? What does AHCO stand for in stocks?

AHCO is the stock ticker symbol of AdaptHealth Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of AdaptHealth Corp (AHCO)?

As of Fri May 10 2024, market cap of AdaptHealth Corp is 1.29 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers. The fair value of AdaptHealth Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of AdaptHealth Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AHCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is AdaptHealth Corp a good stock to buy?

The fair value guage provides a quick view whether AHCO is over valued or under valued. Whether AdaptHealth Corp is cheap or expensive depends on the assumptions which impact AdaptHealth Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AHCO.

What is AdaptHealth Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 10 2024, AHCO's PE ratio (Price to Earnings) is -1.85 and Price to Sales (PS) ratio is 0.4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AHCO PE ratio will change depending on the future growth rate expectations of investors.